CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Agalawatte Plantation Limited Company Snapshot
Agalawatte Plantation Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Agalawatte Plantation Limited with three other miscellaneous service companies in Asia: Medigen Biotechnology Corporation of Taiwan (2015 sales of 363.00 million Taiwanese Dollars [US$12.06 million] of which 82% was Drug Discovery), Japan Tissue Engineering Company Limited of Japan (1.32 billion Japanese Yen [US$11.73 million] of which 93% was Regenerative Medicine Products Business), and Sofiva Genomics Co Ltd which is based in Taiwan (344.40 million Taiwanese Dollars [US$11.44 million] ).

Sales Analysis. Agalawatte Plantation Limited reported sales of 1.83 billion Sri Lanka Rupees (US$11.89 million) for the year ending December of 2015. This represents a decrease of 12.7% versus 2014, when the company's sales were 2.10 billion Sri Lanka Rupees.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Agalawatte Plantation Limited
  Stock Performance Chart for Agalawatte Plantation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2017): 19.00
(Figures in Sri Lanka Rupees)
1 Week -3.1%   13 Weeks -8.2%  
4 Weeks 0.5%   52 Weeks -2.6%  
 
Agalawatte Plantation Limited Key Data:
  Ticker: AGAL.N0000 Country: Sri Lanka
  Exchanges: COL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 1,829,321,000
(Year Ending Jan 2016).
Employees: 7,741
  Currency: Sri Lanka Rupees Market Cap: 475,000,000
  Fiscal Yr Ends: December Shares Outstanding: 25,000,000
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.